Hypertension is one of the major side effects of sorafenib, and reported incidences vary
substantially among clinical trials. A systematic review was conducted using M edline, P ub M ed…

Purpose: To evaluate the efficacy and safety of RC48-ADC, a novel humanized anti-HER2
antibody conjugated with monomethyl auristatin E, in patients with HER2 + locally advanced …

OBJECTIVES: We evaluated a noninvasive method to predict bladder outlet obstruction (BOO)
and bladder function in patients with benign prostatic enlargement (BPE) based on …

The incidence of prostate cancer (PCa) within Asian population used to be much lower than
in the Western population; however, in recent years the incidence and mortality rate of PCa …

NEDD4 links two important molecules associated with targeted therapy and immune
surveillance, providing mechanistic rationale and preclinical support for immuno-targeted …

OBJECTIVES: To assess the safety and efficacy of holmium laser resection for primary,
clinically nonmuscle-invasive, bladder cancer (HoLRBT) compared with standard transurethral …

Purpose: Immunotherapy offers a second-line option for patients with metastatic urothelial
carcinoma (mUC) who failed standard therapy, but the biomarkers for predicting response …

Background Anlotinib is a tyrosine kinase inhibitor inhibiting angiogenesis. This multicenter,
randomized phase II trial aimed to investigate the efficacy and safety of anlotinib in …

These findings demonstrate how reciprocal activation between KIF15 and AR contributes to
enzalutamide resistance in prostate cancer and highlights cotargeting KIF15 and AR as a …

Purpose Enhanced recovery after surgery (ERAS) has played an important role in recovery
management for radical cystectomy with ileal urinary diversion (RC-IUD). This study is to …